top of page

News & press

Apr 15, 2025

CRScube named a G2 leader in spring 2025 reports!

We’re honoured and deeply grateful to be recognized as a Leader on G2.com in their Spring 2025 reports. These reports highlight CRScube as the top performer in usability and return on investment, and we’re humbled by the consistent positive feedback we’ve received from clinical research professionals.

G2 rankings are powered entirely by real user reviews, so this recognition is especially meaningful to us. It reflects the experience of the clinical operations teams, data managers, safety specialists, and site personnel who use our platform every day to run trials more efficiently and with greater confidence.

Designed with purpose, built with care

CRScube was founded with the belief that running a clinical trial shouldn’t be more complicated than it needs to be. Too often, sponsors and CROs find themselves juggling multiple disconnected systems, wasting time on repetitive tasks, and navigating complex interfaces that slow down vital work.

We set out to solve that by building a truly unified eClinical platform, with our Electronic Data Capture (EDC) system at its core, cubeCDMS. All our solutions seamlessly integrate with each other to minimize duplication and maximize efficiency.

The G2 Spring 2025 reports have once again shown that our focus on usability and real-world value is resonating with the clinical research community. Users consistently rate CRScube high for ease of use, speed of implementation, and strong return on investment. It’s incredibly rewarding to see that our efforts are helping streamline the setup and execution of trials, saving both time and resources.

A heartfelt thank you to our product teams

We’d like to take a moment to recognize the incredible work of our product management and development teams, whose insight and empathy lie at the heart of everything we build. They spend countless hours listening to feedback, refining workflows, and collaborating closely with customers to ensure that our products not only meet expectations but often exceed them.

Because of their dedication, new features are introduced with a deep understanding of the daily realities of clinical research. It’s their behind-the-scenes commitment that ensures each update helps sites, CROs and sponsors work more efficiently, reduce risk, and focus more energy on patient outcomes.

Keeping our promise to you

Recognition is always encouraging, but for us, these rankings aren’t the finish line; they’re a reminder of the promise we’ve made to our users. We will continue listening, learning, and improving. We’re committed to keeping our platform simple to adopt, intuitive to use, and powerful enough to handle the complexities of modern clinical trials.

Thank you to everyone who has shared your experience with CRScube on G2. Your reviews don’t just help us grow; they reaffirm our mission to make clinical trials more accessible, efficient and impactful.

Whether you’re a longtime partner or just discovering CRScube, we’re here to support you every step of the way. We’re honoured to walk this journey with you, and we look forward to continuing to earn your trust.

 

Want to see what users are saying about CRScube? Check out our profile on G2.com

placeholder_white_300x300.jpg

Share via

See CRScube in action

Explore how our platform will elevate your team and clinical trial management.

crscube_in_action_ca.avif

Get insights straight to your inbox

img_001.avif

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

Featured resources

icon_01.png

Modern safety reporting in a legacy world – How cubeSAFETY compares, according to CRScube’s COO

Safety reporting is moving beyond simple adverse event collection. The future lies in intelligent risk detection and frictionless data capture.

icon_01.png

Electronic safety reporting in clinical trials: What sponsors need to know

For sponsors and CROs, it is crucial to understand the implications of the full enforcement of ICH E2B(R3) standards, especially as it impacts both pre- and post-authorization submissions.

icon_01.png

From our sales leaders Juan Munoz-Pujol and Scott Robertson

bottom of page